Actionable news
0
All posts from Actionable news
Actionable news in PBYI: PUMA BIOTECHNOLOGY INC,

Puma Biotechnology submits MAA for Neratinib as a treatment of early stage breast cancer in Europe

Puma Biotechnology (PBYI) announces that it has submitted its Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for PB272 (Neratinib). The potential indication is for the extended adjuvant treatment of HER2-positive early stage breast cancer that has previously been treated...


More